» Articles » PMID: 25542427

Single 3-minute Freeze for Second-generation Cryoballoon Ablation: One-year Follow-up After Pulmonary Vein Isolation

Abstract

Background: The second-generation cryoballoon (CB-Adv) is effective in achieving pulmonary vein isolation (PVI) with encouraging results. The mid-term clinical efficacy of a single 3-minute freeze, without a routine bonus application, has been recently demonstrated.

Objective: The purpose of this study was to assess long-term clinical outcome after PVI with the CB-Adv using a single 3-minute application.

Methods: A total of 143 consecutive patients (93 male [65%], mean age 59.6 ± 12.0 years) with paroxysmal atrial fibrillation (PAF; 113/143 [79%]) or early persistent atrial fibrillation (AF; 30/143 [21%]) underwent PVI using CB-Adv with a single 3-minute freeze. Atrial tachyarrhythmia recurrences were defined as symptomatic or documented episodes >30 seconds.

Results: After a single freeze, isolation could be reached in 94.1% of all identified pulmonary veins. Complete PVI was successfully achieved with 1.1 ± 0.4 mean freezes. Persistent phrenic nerve palsy occurred in 5 of 143 patients (3.5%). At a mean 12.1 ± 4.4 months of follow-up, after a 3-month blanking period (BP), 80.4% (115/143) were in stable sinus rhythm (93/113 [82.3%] for PAF; 22/30 [73.3%] for early persistent AF). Fifteen patients underwent a second procedure with radiofrequency ablation showing reconnection in 7 of 15 right-sided (46.7%) and 6 of 15 left-sided (40%) pulmonary veins. Relapses during BP (P <.01), time to PVI (P = .02), and longer AF duration (P = .04) were independent predictors of recurrences.

Conclusion: A single 3-minute freeze is highly effective, determining an atrial tachyarrhythmia freedom of 80.4% at 1-year follow-up. The incidence of persistent phrenic nerve palsy is 3.5%. Relapses during BP, time to PVI, and longer AF duration are predictors of recurrences. Routine use of an "insurance freeze" may not be needed.

Citing Articles

Concurrent assessment of time-to-isolation and temperature at 30 s as an innovative metric for predicting the persistence of pulmonary vein isolation using second-generation cryoballoons.

Wu M, Chen L, Lian L, Chen J, Peng Y, Liao X J Cardiothorac Surg. 2024; 19(1):649.

PMID: 39702441 PMC: 11658157. DOI: 10.1186/s13019-024-03168-x.


Achieving reduced radiation exposure with maintained fluoroscopy effectiveness using ultralow-dose settings in cryoballoon ablation.

Kaneshiro T, Murota S, Nehashi T, Nodera M, Yamada S, Ikeda M J Arrhythm. 2024; 40(6):1400-1407.

PMID: 39669945 PMC: 11632245. DOI: 10.1002/joa3.13179.


Repeat catheter ablation after very late recurrence of atrial fibrillation after pulmonary vein isolation.

Stauffer N, Knecht S, Badertscher P, Krisai P, Hennings E, Serban T Europace. 2024; 26(5).

PMID: 38607938 PMC: 11068271. DOI: 10.1093/europace/euae096.


Difference in tissue temperature change between two cryoballoons.

Hayashi T, Hamada K, Iwasaki K, Takada J, Murakami M, Saito S Open Heart. 2023; 10(2).

PMID: 38065585 PMC: 10711899. DOI: 10.1136/openhrt-2023-002426.


Safety of the Radiofrequency Balloon for Pulmonary Vein Isolation: A Focus on Lesion Metric Analysis of Posterior Electrodes.

Almorad A, Del Monte A, Teumer Y, El Haddad M, Pannone L, Della Rocca D J Clin Med. 2023; 12(19).

PMID: 37834900 PMC: 10573603. DOI: 10.3390/jcm12196256.